|
diabetes care |
3 |
|
follow-up frequency |
3 |
|
individualized care |
3 |
|
type 2 diabetes |
3 |
|
acute care |
2 |
|
costs |
2 |
|
dementia |
2 |
|
healthcare expenditure |
2 |
|
intensive care |
2 |
|
2.12 end of life: critical care |
1 |
|
abdominal aortic aneurysm |
1 |
|
access |
1 |
|
access health care |
1 |
|
access to care |
1 |
|
accessibility of health services |
1 |
|
accident & emergency medicine |
1 |
|
active transportation |
1 |
|
activities of daily living |
1 |
|
acute care costs |
1 |
|
acute myocardial infarction |
1 |
|
acute respiratory distress syndrome |
1 |
|
addictions |
1 |
|
adl |
1 |
|
administrative claims |
1 |
|
administrative data |
1 |
|
administrative health data |
1 |
|
adolescents and young adults |
1 |
|
adult intensive & critical care |
1 |
|
adult intensive & critical care |
1 |
|
adult oncology |
1 |
|
adult orthopaedics |
1 |
|
adult palliative care |
1 |
|
advance care planning |
1 |
|
advance directive adherence |
1 |
|
advance directives |
1 |
|
adverse events |
1 |
|
adverse outcomes |
1 |
|
age |
1 |
|
aged |
1 |
|
aging |
1 |
|
alcohol |
1 |
|
alcohol availability |
1 |
|
alcohol harms |
1 |
|
alcohol policy |
1 |
|
alcohol retail access |
1 |
|
alcohol use disorder |
1 |
|
alcohol use disorders |
1 |
|
alcohol-attributable emergency department visits |
1 |
|
ambulatory care |
1 |
|
anticoagulation |
1 |
|
antiplatelet |
1 |
|
antipsychotics |
1 |
|
antiracism |
1 |
|
anxiety |
1 |
|
anxiety disorder |
1 |
|
ards |
1 |
|
assisted living |
1 |
|
assisted living facilities |
1 |
|
assisted suicide |
1 |
|
assisted-living |
1 |
|
associative factors |
1 |
|
atrial fibrillation |
1 |
|
avoidable mortality |
1 |
|
bariatric surgery |
1 |
|
baseline rates |
1 |
|
bereavement |
1 |
|
bias (epidemiology) |
1 |
|
bleeding |
1 |
|
blood pressure |
1 |
|
bone-targeted agents |
1 |
|
brain injuries |
1 |
|
burden of illness |
1 |
|
burdensome transitions |
1 |
|
burn prevention |
1 |
|
burnout |
1 |
|
canada |
1 |
|
cancer |
1 |
|
cannabis |
1 |
|
cannabis harms |
1 |
|
cannabis legalisation |
1 |
|
cannabis retail |
1 |
|
cannabis use disorder |
1 |
|
carcinoma |
1 |
|
cardiac arrest |
1 |
|
cardiogenic shock |
1 |
|
cardiovascular disease |
1 |
|
cardiovascular events |
1 |
|
care |
1 |
|
care alignment |
1 |
|
care quality |
1 |
|
care transitions |
1 |
|
care-receiver’s gender |
1 |
|
caregiver distress |
1 |
|
case ascertainment |
1 |
|
case series |
1 |
|
cerebral hemorrhage |
1 |
|
chemotherapy |
1 |
|
chickenpox vaccine |
1 |
|
children |
1 |
|
chronic |
1 |
|
chronic critical illness |
1 |
|
chronic disease |
1 |
|
chronic diseases |
1 |
|
chronic kidney disease |
1 |
|
chronic kidney disease (ckd) |
1 |
|
chronic obstructive |
1 |
|
chronic obstructive pulmonary disease |
1 |
|
cirrhosis |
1 |
|
ckd |
1 |
|
clinical decision-making |
1 |
|
clinical ethics |
1 |
|
clinical guidelines |
1 |
|
cognitive decline |
1 |
|
cognitive dysfunction |
1 |
|
cognitive function |
1 |
|
cognitive impairment |
1 |
|
cohort studies |
1 |
|
cohort study |
1 |
|
colon cancer |
1 |
|
commercialisation |
1 |
|
commercialization |
1 |
|
communication |
1 |
|
community based care |
1 |
|
community-based participatory research methods |
1 |
|
community–institutional relations |
1 |
|
complex continuing care |
1 |
|
computer simulation |
1 |
|
continuing care |
1 |
|
continuity |
1 |
|
continuity of care |
1 |
|
continuity of patient care |
1 |
|
conversation guide |
1 |
|
cost |
1 |
|
cost analysis |
1 |
|
cost and cost analysis |
1 |
|
cost-effectiveness |
1 |
|
costs and cost analysis |
1 |
|
covid-19 |
1 |
|
covid-19 positivity |
1 |
|
covid-19 prioritization |
1 |
|
covid-19 triage or prioritization |
1 |
|
covid-19 vaccine safety |
1 |
|
critical care |
1 |
|
critical illness |
1 |
|
critically ill |
1 |
|
cultural competency |
1 |
|
data collection |
1 |
|
days at home |
1 |
|
death |
1 |
|
decedent |
1 |
|
decision making |
1 |
|
decompensation |
1 |
|
delirium |
1 |
|
delivery of health care |
1 |
|
delivery of healthcare |
1 |
|
democratic deliberation |
1 |
|
demography |
1 |
|
denosumab |
1 |
|
dependency |
1 |
|
depression |
1 |
|
determinants of home death |
1 |
|
determinants of nursing home death |
1 |
|
determinants of place of death |
1 |
|
diabetes |
1 |
|
diabetic ketoacidosis |
1 |
|
diagnostic testing |
1 |
|
dialysis |
1 |
|
direct oral anticoagulants (doacs) |
1 |
|
discharge planning |
1 |
|
disease modeling |
1 |
|
disease trajectories |
1 |
|
disposition |
1 |
|
dnr |
1 |
|
do-not-hospitalize |
1 |
|
do-not-resuscitate |
1 |
|
dopps |
1 |
|
dwelling place |
1 |
|
dynamic assessment |
1 |
|
dynamic hip screws |
1 |
|
dyspnea |
1 |
|
early detection |
1 |
|
early medical intervention |
1 |
|
early warning systems |
1 |
|
ecmo |
1 |
|
ed |
1 |
|
ed visits |
1 |
|
ed visits due to cannabis |
1 |
|
effect modifiers (epidemiology) |
1 |
|
egfr |
1 |
|
ehealth |
1 |
|
elderly |
1 |
|
elders |
1 |
|
emergency department |
1 |
|
emergency department visits |
1 |
|
emergency departments |
1 |
|
enablers and barriers |
1 |
|
end of life |
1 |
|
end of life care |
1 |
|
end-of-life |
1 |
|
end-of-life care |
1 |
|
end-of-life medications |
1 |
|
end-of-life transitions |
1 |
|
end-stage kidney disease |
1 |
|
endocrinology |
1 |
|
epidemiologic methods |
1 |
|
epidemiology |
1 |
|
estimated glomerular filtration rate (egfr) |
1 |
|
ethnic concentration |
1 |
|
ethnic minorities |
1 |
|
euthanasia |
1 |
|
evaluation |
1 |
|
exploratory factor analysis |
1 |
|
extracorporeal membrane oxygenation |
1 |
|
extubation failure |
1 |
|
fall |
1 |
|
family medicine |
1 |
|
first nation |
1 |
|
fluid responsiveness |
1 |
|
fluid therapy |
1 |
|
frailty |
1 |
|
francophones |
1 |
|
functional status |
1 |
|
gastrointestinal bleeding |
1 |
|
general medicine (see internal medicine) |
1 |
|
general practice |
1 |
|
geriatric medicine |
1 |
|
geriatrics |
1 |
|
goal directed |
1 |
|
goal-concordant care |
1 |
|
grief |
1 |
|
harmful events |
1 |
|
health administrative data |
1 |
|
health behavior |
1 |
|
health care |
1 |
|
health care administrative claims |
1 |
|
health care cost |
1 |
|
health care costs |
1 |
|
health care services |
1 |
|
health care utilization |
1 |
|
health determinants |
1 |
|
health disparities |
1 |
|
health economics |
1 |
|
health equity |
1 |
|
health informatics |
1 |
|
health outcomes |
1 |
|
health planning |
1 |
|
health policy |
1 |
|
health promotion |
1 |
|
health service research |
1 |
|
health service use |
1 |
|
health service utilization |
1 |
|
health services |
1 |
|
health services accessibility |
1 |
|
health services needs and demand |
1 |
|
health services utilization |
1 |
|
health services, indigenous |
1 |
|
health system measures |
1 |
|
health-care economics |
1 |
|
healthcare |
1 |
|
healthcare costs |
1 |
|
healthcare disparities |
1 |
|
healthcare economics |
1 |
|
healthcare use |
1 |
|
heart failure |
1 |
|
hematology |
1 |
|
hemodialysis |
1 |
|
hemorrhage |
1 |
|
herpes zoster |
1 |
|
high cost users |
1 |
|
high intensity care |
1 |
|
high-cost user |
1 |
|
high-cost users |
1 |
|
hip |
1 |
|
hip fracture |
1 |
|
hiv |
1 |
|
home |
1 |
|
home care |
1 |
|
home care services |
1 |
|
home-based palliative care |
1 |
|
hospital |
1 |
|
hospital admission |
1 |
|
hospital care |
1 |
|
hospital costs |
1 |
|
hospital transfer |
1 |
|
hospital-based care |
1 |
|
hospitalization |
1 |
|
hospitalizations |
1 |
|
hospitals, public |
1 |
|
house calls |
1 |
|
hypertension |
1 |
|
hypertensive disorders of pregnancy |
1 |
|
hypotension |
1 |
|
ices |
1 |
|
icu costs |
1 |
|
icu los |
1 |
|
immigrant |
1 |
|
immigrants |
1 |
|
immunization programs |
1 |
|
impella |
1 |
|
in-hospital cardiac arrest |
1 |
|
inappropriate prescribing |
1 |
|
incidence |
1 |
|
indigenous |
1 |
|
infectious diseases |
1 |
|
information technology |
1 |
|
inpatient |
1 |
|
inpatient palliative care |
1 |
|
inpatients |
1 |
|
institutionalization |
1 |
|
intensive care unit |
1 |
|
intermediate care |
1 |
|
internal medicine |
1 |
|
international |
1 |
|
interrupted time-series |
1 |
|
intertrochanteric hip fractures |
1 |
|
intracerebral hemorrhage |
1 |
|
intracranial hemorrhage |
1 |
|
intramedullary nails |
1 |
|
inuit |
1 |
|
kidney failure |
1 |
|
kidney function |
1 |
|
kidney health |
1 |
|
language |
1 |
|
language as a determinant of health |
1 |
|
language barriers |
1 |
|
language concordance |
1 |
|
language discordance |
1 |
|
legalization |
1 |
|
lengths of stay |
1 |
|
life expectancy |
1 |
|
life-prolonging therapy |
1 |
|
life-threatening conditions |
1 |
|
linguistic factors |
1 |
|
linguistic group |
1 |
|
linguistic groups |
1 |
|
linguistic minorities |
1 |
|
linguistic variables |
1 |
|
location of death |
1 |
|
logistic model |
1 |
|
long-term care |
1 |
|
long-term care admission |
1 |
|
long-term outcomes |
1 |
|
low-income neighborhoods |
1 |
|
lung neoplasms |
1 |
|
lung-protective ventilation |
1 |
|
mace |
1 |
|
machine learning model |
1 |
|
major bleeding |
1 |
|
malignancy |
1 |
|
marginalization |
1 |
|
marijuana |
1 |
|
material deprivation |
1 |
|
mechanical circulatory support |
1 |
|
mechanical ventilation |
1 |
|
medical assistance in dying |
1 |
|
medical education |
1 |
|
medical education & training |
1 |
|
medical models of care |
1 |
|
medications |
1 |
|
mental health |
1 |
|
mental illness |
1 |
|
mesothelioma |
1 |
|
meta-analysis |
1 |
|
metric |
1 |
|
modifiable behaviors |
1 |
|
morbidity |
1 |
|
mortality |
1 |
|
mortality determinants |
1 |
|
multimorbidity |
1 |
|
myocardial infarction |
1 |
|
métis |
1 |
|
nested case-control studies |
1 |
|
non-medical cannabis legalisation |
1 |
|
nonmalignant illnesses |
1 |
|
nonprofit organizations |
1 |
|
nursing home |
1 |
|
nursing home care |
1 |
|
nursing homes |
1 |
|
obesity |
1 |
|
observational studies |
1 |
|
observational study |
1 |
|
older adult |
1 |
|
older adults |
1 |
|
older men |
1 |
|
older women |
1 |
|
omega-3 |
1 |
|
oncology |
1 |
|
online democratic deliberation |
1 |
|
online health |
1 |
|
ontario |
1 |
|
ontario/epidemiology |
1 |
|
opioid use |
1 |
|
opioids |
1 |
|
oral anticoagulant |
1 |
|
orthopedic rehabilitation |
1 |
|
overdose |
1 |
|
pain |
1 |
|
pain management |
1 |
|
palliative |
1 |
|
palliative care |
1 |
|
palliative homecare |
1 |
|
palliative medicine |
1 |
|
pancreatic cancer |
1 |
|
pancreatic ductal |
1 |
|
pandemic |
1 |
|
parkinson's disease |
1 |
|
patient admission |
1 |
|
patient communication |
1 |
|
patient discharge |
1 |
|
patient enrolment |
1 |
|
patient harm |
1 |
|
patient reported outcomes |
1 |
|
patient safety |
1 |
|
patient-centered care |
1 |
|
patient-centered outcomes |
1 |
|
pediatric burns |
1 |
|
pediatrics |
1 |
|
physical activity |
1 |
|
physician |
1 |
|
physician hastened death |
1 |
|
physician health |
1 |
|
physician practice |
1 |
|
physicians |
1 |
|
physicians’ practice patterns |
1 |
|
physiological decline |
1 |
|
place of care |
1 |
|
place of care trajectories |
1 |
|
place of death |
1 |
|
poisoning |
1 |
|
policy |
1 |
|
population |
1 |
|
population health |
1 |
|
population projection |
1 |
|
population surveillance |
1 |
|
population-based planning |
1 |
|
population-based research |
1 |
|
population-level |
1 |
|
positive airway pressure treatment |
1 |
|
post-intensive care syndrome |
1 |
|
post-operative rehabilitation outcomes |
1 |
|
post-surgery |
1 |
|
postintensive care syndrome |
1 |
|
post–intensive care syndrome |
1 |
|
potentially inappropriate prescribing |
1 |
|
potentially preventable emergency department transfer |
1 |
|
practice patterns |
1 |
|
prediction model |
1 |
|
preeclampsia |
1 |
|
preference for place of death |
1 |
|
pregnancy |
1 |
|
prescription drugs |
1 |
|
prevalence |
1 |
|
prevention |
1 |
|
previously collected data |
1 |
|
primary care |
1 |
|
primary care physicians |
1 |
|
primary health care |
1 |
|
problematic substance use |
1 |
|
prognosis |
1 |
|
prolonged grief disorder |
1 |
|
proprietary |
1 |
|
prostate cancer |
1 |
|
protective factors |
1 |
|
public health |
1 |
|
public health practice |
1 |
|
public health systems research |
1 |
|
publicly funded vaccination programs |
1 |
|
pulmonary disease |
1 |
|
qualitative |
1 |
|
qualitative research |
1 |
|
quality and safety |
1 |
|
quality assessment |
1 |
|
quality improvement |
1 |
|
quality in health care |
1 |
|
quality indicators |
1 |
|
quality of care |
1 |
|
quality of life |
1 |
|
quick sequential organ failure assessment |
1 |
|
randomized controlled trials |
1 |
|
rapid response team |
1 |
|
rapid response teams |
1 |
|
readmission |
1 |
|
recreational cannabis commercialization |
1 |
|
recreational cannabis legalisation |
1 |
|
recreational cannabis legalization |
1 |
|
recurrent deterioration |
1 |
|
red blood cell |
1 |
|
reflexive thematic analysis |
1 |
|
refugee |
1 |
|
refugees |
1 |
|
regional cancer center |
1 |
|
registries |
1 |
|
rehabilitation |
1 |
|
rehabilitation medicine |
1 |
|
relational continuity of care |
1 |
|
remote consultation |
1 |
|
reporting guidelines |
1 |
|
research ethics |
1 |
|
research methodology |
1 |
|
residential aged care |
1 |
|
residential instability |
1 |
|
residents |
1 |
|
resource allocation |
1 |
|
resource utilization |
1 |
|
resuscitation |
1 |
|
retail access |
1 |
|
retirement homes |
1 |
|
retrospective cohort |
1 |
|
retrospective studies |
1 |
|
risk |
1 |
|
risk assessment |
1 |
|
risk factors |
1 |
|
risk prediction models |
1 |
|
risk reduction |
1 |
|
risk stratification |
1 |
|
risk–benefit trade-offs |
1 |
|
routinely collected data |
1 |
|
routinely collected health data |
1 |
|
rural |
1 |
|
rural health |
1 |
|
sars-cov-2 |
1 |
|
sars-cov-2 infection |
1 |
|
schizophrenia |
1 |
|
self-harm |
1 |
|
semi-structured interviews |
1 |
|
seniors' residence |
1 |
|
sepsis |
1 |
|
sepsis-3 |
1 |
|
septic shock |
1 |
|
service utilization |
1 |
|
skeletal-related events |
1 |
|
sleep disordered breathing |
1 |
|
smoking |
1 |
|
social determinants of health |
1 |
|
social justice |
1 |
|
socioeconomic factors |
1 |
|
specialist palliative care |
1 |
|
statistical models |
1 |
|
statistics & research methods |
1 |
|
step-down units |
1 |
|
stroke |
1 |
|
structural equation modeling |
1 |
|
subarachnoid hemorrhage |
1 |
|
substance use |
1 |
|
substance use disorders |
1 |
|
substance-related disorders |
1 |
|
suicide |
1 |
|
surgery |
1 |
|
survival |
1 |
|
syncope |
1 |
|
systematic review |
1 |
|
systematic reviews as topic |
1 |
|
target population |
1 |
|
target trial emulation |
1 |
|
telehealth |
1 |
|
telemedicine |
1 |
|
terminal care |
1 |
|
terminal hospitalization |
1 |
|
terminal hospitalizations |
1 |
|
thematic analyses |
1 |
|
theoretical models |
1 |
|
thromboembolic |
1 |
|
thromboprophylaxis |
1 |
|
tiebreakers |
1 |
|
toxicology |
1 |
|
tracheostomy |
1 |
|
transfusion |
1 |
|
transition |
1 |
|
transitional care |
1 |
|
traumatic brain injury |
1 |
|
treatment preferences |
1 |
|
underserved populations |
1 |
|
utilization |
1 |
|
vaccination |
1 |
|
validity |
1 |
|
varicella vaccines |
1 |
|
venous thromboembolism |
1 |
|
vitamin k antagonists (vkas) |
1 |
|
wait time |
1 |
|
waitlist |
1 |
|
warfarin |
1 |
|
weight loss surgery |
1 |
|
weight recidivism |
1 |
|
weight regain |
1 |
|
wellness |
1 |
|
women's health |
1 |
|
young adults |
1 |
|
zoledronate |
1 |
